shRNA-mediated knockdown as well as CRISPR/Cas9-induced mutagenesis of SETD2 caused proliferation arrest and myeloid differentiation of MLL-fusion-expressing primary and transformed human, and mouse AML cells in vitro and in vivo. This evidence concerns the gene SETD2 and acute myeloid leukemia.